Get Real Time Here
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
NeuBase Therapeutics Stock (NASDAQ:NBSE), Quotes and News Summary
NeuBase Therapeutics Stock (NASDAQ: NBSE) stock price, news, charts, stock research, profile.
| Open- | Close- |
| Vol / Avg.1.751K / 2.327M | Mkt Cap3.170M |
| Day Range- - - | 52 Wk Range0.605 - 8.700 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2022-10-21 | Oppenheimer | Hartaj Singh | Downgrades | OutperformPerform | - | - | - |
| 2022-10-18 | RBC Capital | Leonid Timashev | Downgrades | OutperformSector Perform | Lowers | 12.00 | 1.00 |
| 2022-10-17 | Chardan Capital | Keay Nakae | Downgrades | BuyNeutral | - | - | - |
| 2022-08-12 | Chardan Capital | Keay Nakae | Maintains | Buy | Lowers | 9.00 | 7.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NBSE | NeuBase Therapeutics | -2.28% | 3.2M |
| PSTV | Plus Therapeutics | -5.22% | 3.7M |
| PBLA | Panbela Therapeutics | -1.53% | 3.8M |
| THAR | Tharimmune | -7.5% | 3.3M |
| DRMA | Dermata Therapeutics | 0.94% | 3.4M |
How do I buy NeuBase Therapeutics (NBSE) stock?
You can purchase shares of NeuBase Therapeutics (NASDAQ: NBSE) through any online brokerage.
Who are NeuBase Therapeutics's (NBSE) competitors?
Other companies in NeuBase Therapeutics’s space includes: Plus Therapeutics (NASDAQ:PSTV), Panbela Therapeutics (NASDAQ:PBLA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA) and Biocept (NASDAQ:BIOC).
What is the target price for NeuBase Therapeutics (NBSE) stock?
The latest price target for NeuBase Therapeutics (NASDAQ: NBSE) was reported by Oppenheimer on Friday, October 21, 2022. The analyst firm set a price target for 0.00 expecting NBSE to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Current Stock Price for NeuBase Therapeutics (NBSE)?
The stock price for NeuBase Therapeutics (NASDAQ: NBSE) is $0.85 last updated Today at October 2, 2023 at 9:06 AM UTC.
Does NeuBase Therapeutics (NBSE) pay a dividend?
There is no dividend information for NeuBase Therapeutics.
When is NeuBase Therapeutics (NASDAQ:NBSE) reporting earnings?
NeuBase Therapeutics’s Q4 earnings are confirmed for Wednesday, December 20, 2023.
Is NeuBase Therapeutics (NBSE) going to split?
There is no upcoming split for NeuBase Therapeutics.
What sector and industry does NeuBase Therapeutics (NBSE) operate in?
NeuBase Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.